Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
Wada, I
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome. [electronic resource] - Journal of assisted reproduction and genetics Apr 1995 - 252-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
1058-0468
10.1007/BF02212927 doi
Adult
Buserelin--adverse effects
Dose-Response Relationship, Drug
Embryo Transfer
Estradiol--blood
Female
Fertilization in Vitro
Gonadotropins--therapeutic use
Humans
Leuprolide--therapeutic use
Menotropins--adverse effects
Menstrual Cycle
Ovarian Hyperstimulation Syndrome--epidemiology
Ovulation Induction
Pregnancy
Pregnancy Outcome
Radioimmunoassay
Risk Factors
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome. [electronic resource] - Journal of assisted reproduction and genetics Apr 1995 - 252-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
1058-0468
10.1007/BF02212927 doi
Adult
Buserelin--adverse effects
Dose-Response Relationship, Drug
Embryo Transfer
Estradiol--blood
Female
Fertilization in Vitro
Gonadotropins--therapeutic use
Humans
Leuprolide--therapeutic use
Menotropins--adverse effects
Menstrual Cycle
Ovarian Hyperstimulation Syndrome--epidemiology
Ovulation Induction
Pregnancy
Pregnancy Outcome
Radioimmunoassay
Risk Factors